Patients and healthcare providers in the United States can learn more about QINLOCK® (ripretinib) by visiting the product websites below or by accessing the prescribing information.
Patients and healthcare providers in the United States can learn more about ROMVIMZA® (vimseltinib) by visiting the product websites below or by accessing the prescribing information.
Personalized support and financial assistance for eligible U.S. patients receiving QINLOCK® or ROMVIMZA®.
Compliance and State Disclosures
The following are registered trademarks of Deciphera Pharmaceuticals, LLC: QINLOCK, the QINLOCK logo, ROMVIMZA, the ROMVIMZA logo, DECIPHERA, and the Deciphera logo.